Antimalarial cabamiquine inhibits blood-stage of different field isolates of Plasmodium species

Abstract Malaria remains a major public health concern in Sub-Saharan Africa. The widespread and emerging drug resistance calls for urgent development of new drugs with novel modes of action to treat, control, and eliminate malaria. Cabamiquine, a promising antimalarial drug candidate that inhibits...

Descripció completa

Dades bibliogràfiques

Autors principals:	Laurent Dembele, Yaw Aniweh, Alamissa Soulama, Fanta Sogore, Ousmaila Diakité, Fatoumata Diallo, François Dao, Lucas N. Amenga-Etego, Claudia Demarta-Gatsi, Thomas Spangenberg, Abdoulaye A. Djimde
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2026-04-01
Col·lecció:	BMC Infectious Diseases
Matèries:	Cabamiquine Non-falciparum Antimalarial Susceptibility Malaria Efficacy
Accés en línia:	https://doi.org/10.1186/s12879-026-13242-5
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!